
Shares of drug distributor McKesson MCK.N rise 4.5% to $721
MCK late on Thursday forecast fiscal year 2026 profit largely above estimates
Company said it is planning to spin off its medical-surgical solutions unit into an independent company to focus on its core drug distribution business
Expects per-share profit in the range of $36.75 to $37.55 for 2026, compared with analysts' average estimate of $36.76 -data compiled by LSEG
Posted Q4 earnings of $10.12 per share vs estimate of $9.82 per share
Including session's moves, stock up 21.1% YTD